Get started
Author

Aurélien Gobert

Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study
2018 · Joe-Elie Salem, Ali Manouchehri, et al. · The Lancet Oncology · 1,337
PDF
EGFR-independent mechanisms of acquired resistance to AZD9291 in EGFR T790M-positive NSCLC patients
2015 · D. Planchard, Y. Loriot, et al. · Annals of Oncology · 317
Immunotherapy for cancer in people living with HIV: safety with an efficacy signal from the series in real life experience
2019 · Jean-Philippe Spano, Marianne Veyri, et al. · AIDS · 74
Robotic radical nephroureterectomy and segmental ureterectomy for upper tract urothelial carcinoma: a multi-institutional experience
2019 · Riccardo Campi, Juliette Cotte, et al. · World Journal of Urology · 52
Real-world Study of Avelumab First-line Maintenance Treatment in Patients with Advanced Urothelial Carcinoma in France: Overall Results from the Noninterventional AVENANCE Study and Analysis of Outcomes by Second-line Treatment
2024 · Philippe Barthélémy, Constance Thibault, et al. · European Urology Oncology · 46
Non-clear cell renal carcinomas: Review of new molecular insights and recent clinical data
2021 · Philippe Barthélémy, Nathalie Rioux-Leclercq, et al. · Cancer Treatment Reviews · 40
PDF
Neuroendocrine Carcinoma of the Urinary Bladder: A Large, Retrospective Study From the French Genito-Urinary Tumor Group
2019 · Marine Sroussi, Reza Elaidi, et al. · Clinical Genitourinary Cancer · 27
Updated results from AVENANCE: Real-world effectiveness of avelumab first-line maintenance (1LM) in patients (pts) with advanced urothelial carcinoma (aUC) and analysis of subsequent treatment.
2024 · Philippe Barthelemy, Yohann Loriot, et al. · Journal of Clinical Oncology · 22
PDF
Morbidity, perioperative outcomes and complications of robot-assisted radical prostatectomy in kidney transplant patients: A French multicentre study
2020 · Margaux Felber, Sarah J. Drouin, et al. · Urologic Oncology Seminars and Original Investigations · 18
PDF
Full analysis from AVENANCE: A real-world study of avelumab first-line (1L) maintenance treatment in patients (pts) with advanced urothelial carcinoma (aUC).
2023 · Philippe Barthelemy, Yohann Loriot, et al. · Journal of Clinical Oncology · 16
RECIST and CHOI criteria in the evaluation of tumor response in patients with metastatic colorectal cancer treated with regorafenib, a prospective multicenter study
2019 · Olivier Lucidarme, Mathilde Wagner, et al. · Cancer Imaging · 14
PDF
Outcomes after salvage radical prostatectomy and first-line radiation therapy or HIFU for recurrent localized prostate cancer: results from a multicenter study
2019 · Romain Clery, Pietro Grande, et al. · World Journal of Urology · 10
Bladder mapping of tumour recurrence after radical nephroureterectomy for upper tract urothelial carcinoma and its influence on oncological outcomes
2018 · Yassine Belhadj, Pietro Grande, et al. · British Journal of Urology · 10
VIH et Cancer: état Des Connaissances
2014 · Aurélien Gobert, Nicolas Mounier, et al. · Bulletin du Cancer · 10
Cancer de prostate métastatique résistant à la castration et inhibiteurs de PARP : de la génomique tumorale aux nouvelles associations thérapeutiques
2024 · Stéphane Oudard, Marc-Olivier Timsit, et al. · Bulletin du Cancer · 5
HIV-associated cancers: the role of a unique multidisciplinary board to optimize patient’s care behalf the CANCERVIH Group
2018 · Aurelien Gobert, Jean-Philippe Spano, et al. · Medical Oncology · 5
PARP Inhibitors in Metastatic Castration-resistant Prostate Cancer: Rationale, Mechanisms, and Clinical Applications
2025 · Stéphane Oudard, Marc-Olivier Timsit, et al. · European Urology Oncology · 3
Prevention and management of PARP inhibitor-related haematological toxicities in prostate cancer: French expert opinion using the Delphi method
2025 · Ophélie Cassuto, Romain Mathieu, et al. · Therapeutic Advances in Medical Oncology · 3
Tolerance and efficacy of immune-checkpoint inhibitors for cancer in people living with HIV (PWHIV)
2018 · A. Gobert, M. Veyri, et al. · Annals of Oncology · 3
Cancer et VIH : actualités 2017
2018 · Aurélien Gobert, Marianne Veyri, et al. · Bulletin du Cancer · 2
Long-term real-world outcomes of nivolumab+ipilimumab treatment of unresectable pleural mesothelioma: update of Meso-Immune GFPC 04-2021 study
2026 · Jean-Baptiste Assié, Laurent Greillier, et al. · Lung Cancer · 1
Comment prévenir et gérer les toxicités hématologiques liées aux inhibiteurs de PARP dans le cancer de la prostate ?
2026 · Ophélie Cassuto, Antonin Schmitt, et al. · Bulletin du Cancer · 1
PDF
Real-life efficacy of nivolumab plus ipilimumab combination in untreated, unresectable malignant pleural mesotheliomas: Result of French early access program—MESOIMMUNE – GFPC 04-2021.
2023 · Olivier Bylicki, Florian Guisier, et al. · Journal of Clinical Oncology · 1
Efficacy and prognostic factors of systemic therapies for metastatic adenoid cystic carcinoma.
2019 · Cyril Roussel-Simonin, Francois Riet, et al. · Journal of Clinical Oncology · 1
Neuroendocrine carcinoma of the urinary bladder: A large analysis of the French GETUG consortium
2018 · M. Sroussi, M. Lorcet, et al. · Annals of Oncology · 1
Works count: 43
Citation count: 2,024
H-index: 11
I10-index: 14
Year
Topic
Type